New Delhi: Drug firm Lupin today said it has received approval from the US health regulator for its generic Ziprasidone Hydrochloride capsules, used for treating mentaldisorders in the American market.The company`s subsidiary Lupin Pharmaceuticals Inc has received final approval for its Ziprasidone Hydrochloride capsules in the strengths of 20 mg, 40 mg, 60 mg and 80 mgfrom the United States Food and Drug Administration (USFDA), Lupin said in a statement.The capsules are generic equivalent of Pfizer Inc`s Geodon capsules in the same strengths and the firm has already commenced shipping them, it added."Pfizer`s Geodon capsules had sales of USD 1.35 billion as per IMS Health, December 2011, Lupin said.
Chhattisgarh: 20 jawans feared dead in Naxal attack
Gujarat is shining for industrialists: Rahul Gandhi
Modi slams Nitish Kumar in Bihar rally
AAP leader Ashwin Upadhyay calls Arvind Kejriwal `CIA agent`